Analyst Activity – BNP Paribas Reiterates Neutral on Aberdeen Asset Management plc (LON:ADN)

Analyst Ratings For Aberdeen Asset Management plc (LON:ADN)

Story continues below

Today, BNP Paribas reiterated its Neutral rating on Aberdeen Asset Management plc (LON:ADN) with a price target of GBX 300.

There are 3 sell ratings, 11 hold ratings, 3 buy ratings on the stock.

The current consensus rating on Aberdeen Asset Management plc (LON:ADN) is Hold (Score: 2.00) with a consensus target price of GBX 295 per share, a potential .

Some recent analyst ratings include

  • 7/18/2017-BNP Paribas Reiterated Rating of Neutral.
  • 7/14/2017-HSBC Holdings plc Upgrade from a “Buy” rating to a “” rating.
  • 6/15/2017-Berenberg Bank initiated coverage with a Hold rating.
  • 6/7/2017-Morgan Stanley Upgrade from a “Equal weight” rating to a “” rating.
  • 5/15/2017-Macquarie Reiterated Rating of Neutral.
  • 5/4/2017-Numis Securities Ltd was Downgraded by analysts at Numis Securities Ltd from a “Add” rating to a “” rating. They now have a GBX 338 price target on the stock, up previously from GBX 332 .

    Recent Trading Activity for Aberdeen Asset Management plc (LON:ADN)
    Shares of Aberdeen Asset Management plc closed the previous trading session at 316.90 up +2.20 0.70% with 1,402,170 shares trading hands.

    An ad to help with our costs